Discrimination between low dietary zinc and endotoxin exposure: a model study on weaning rats

The cytotoxic effect of endotoxin on bone marrow cells in zinc deficient rats

The cytotoxic effect of bacterial lipopolisaccharide (LPS) on bone marrow cells was studied using normal and zinc deficient rats. LPS is known to release cytokines from macrophages such as TNF, IL-1, IL-6 and induce metallothionein (MT) in the liver, kidney, heart, etc. The bone marrow in zinc deficient rats with low MT levels was shown to be highly injured by 2 mg/kg LPS administration, indicating a significant decrease of bone marrow cells and an increase of adipocytes. No significant injury was observed in the rats fed with normal diet by the same dose of LPS administration. Low zinc level or low MT induction in bone marrow cells was discussed with relation to the cytotoxic effect of LPS to those cells.

The role of the pancreas in the regulation of zinc status

A low Zn diet resulted in subacute Zn deficiency in young rats. Thirty minutes after the intubation of a trace 65-Zn we determined the total tissue Zn activity in plasma, erythrocytes, liver, pancreas, bone, muscle, and proximal jejunum. Assuming the body behaved like a closed multicompartmental system in steady state, we estimated the initial Zn exchange between plasma, and the erythrocytes or these tissues. In comparison with control animals the exchanges between plasma and erythrocytes or pancreas increased threefold during subacute Zn deficiency. In the pancreas the ratio also reversed from < 1.0 to > 1.0. This confirmed earlier observations that the specific activity (kBq 65-Zn/mol Zn) increased mostly in the pancreas. By increased net Zn uptake during subacute deficiency, the pancreas Zn content remained constant in chronic Zn deficiency. We discussed the regulation of the Zn status by the pancreas. We hypothesize that the exocrine pancreas modulates Zn absorption by an exocrine ligand that enhances absorption in the jejunum during subacute deficiency: Unsaturated with Zn it binds dietary intraluminal Zn and increases the Zn absorption. The literature provides evidence in confirmation. This hypothesis explains also conflicting data on the inherited Zn malabsorption syndrome Acrodermatitis Enteropathica.

Changes of zinc values in children during malignant disease

In 47 children with malignancy, zinc status, growth, and performance during standard treatment were compared with those in controls. At diagnosis, growth was retarded and hair zinc values were high, 2.4 +/- 0.7 mumol/g, as in chronic deficiency. During induction therapy, serum declined to 10.4 +/- 2.3 mumol/L and urinary excretion increased to 5.3 +/- 2.8 mumol/mol creatinine, as in acute exacerbation of deficiency. Control CSF values in children in remission, 0.04 +/- 0.01 mumol/L, were lower than reference values in adults. No difference in mean CSF zinc was observed during therapy, or in those with acute lymphoblastic leukemia (1) at high risk, (2) with central nervous system involvement, (3) with low performance, or (4) resistant to therapy. In six children unexplained values, up to 0.28 mumol/L during induction, were measured. No correlations between the various zinc parameters were found.